Telix, Grupo RPH ink production & distribution agreement in Brazil
Category: #health  By Mateen Dalal  Date: 2019-07-03
  • share
  • Twitter
  • Facebook
  • LinkedIn

Telix, Grupo RPH ink production & distribution agreement in Brazil

The agreement gives Grupo RPH exclusive right to manufacture and distribute the TLX591-Cdx in the Latin American market

Clinical-stage biopharmaceutical firm Telix Pharmaceutical has reportedly signed a manufacturing and distribution agreement with Grupo RPH.

Grupo RPH will become the contract manufacturer as well as distributor for Telix in Brazil. According to an official statement, their initial focus as partners will be on TLX591-CDx (68Ga-PSMA-11) for prostate cancer imaging, but the contract agreement is built so as to allow Telix to include other products as well later on.

Rafael Madke, Grupo RPH Managing Director stated that Telix’s rapid expansion over the past year has been remarkable, and with Grupo RPH holding the upper hand in the Brazilian market owing to its proficiency to fabricate and distribute radiopharmaceuticals, the company will be able to support Telix’s commercial goals cost-effectively.

Telix Vice President for Corporate Development, Ludovic Wouters was quoted saying that the alliance offers their gallium-68 based nuclear medicinal products a massive and rapidly growing market. He further added they were looking forward to working with Grupo RPH to introduce their prostate cancer imaging technology into the Latin American market.

For the uninitiated, Telix Pharmaceuticals Limited is a global clinical-stage biopharmaceutical corporation aimed at the development of therapeutic and diagnostic radiopharmaceutical products based on molecularly targeted radiation (MTR). The Melbourne-headquartered company has international businesses in Indianapolis (US), Brussels (UK), and Kyoto (Japan).

Supposedly, the company is aiming to develop a portfolio of clinical-stage oncology offerings which can tackle numerous unmet needs of patients with prostate, renal and brain cancer.

Grupo RPH commercially offers 8 different Cold Kits for Ga68 and Tc99m manufacturing in the Brazilian market. The firm also owns the GMP manufacturing facility based in Brazil for radiopharmaceutical products and exports its products throughout the country for serving more than 400 customers every day. The company is also known to have pioneered Brazil’s centralized radio-pharmacy model.

 

Source credit: https://www.globenewswire.com/news-release/2019/07/03/1877635/0/en/Telix-Pharmaceuticals-and-Grupo-RPH-Sign-LATAM-Manufacturing-and-Distribution-Agreement.html?print=1

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

Mateen has completed his Bachelor’s degree in electronics and telecommunication engineering, post which he lent his proficiency to the industry, working as a quality and test engineer. Drawn intricately toward the field of content creation however, Mateen soon switc...

Read More

More News By Mateen Dalal

Google’s business intelligence platform Looker collabs with Tableau
Google’s business intelligence platform Looker collabs with Tableau
By Mateen Dalal

Google Cloud Platform has recently revealed that its business intelligence platform, Looker has been integrated with Tableau, empowering users of both the platforms to benefit from the different features offered by each. For starters, Google Cloud a...

HR tech firm Personio ropes in $270 million in latest financing round
HR tech firm Personio ropes in $270 million in latest financing round
By Mateen Dalal

Personio, a HR software provider targeting small and medium sized businesses, has attained a $270 million investment in the wake of high demand for its services. With the latest Series E round of funding, Personio's valuation roses to $6.3 billi...

New Zealand prepares to deal with potential surge in COVID-19 cases
New Zealand prepares to deal with potential surge in COVID-19 cases
By Mateen Dalal

New Zealand is preparing for an increase in Covid-19 cases after registering 94 new infections over the weekend, with pandemic modelers predicting that if the government continues on its present path, new cases would rapidly exceed 100 per day. Epid...